Compounds useful in the treatment of neoplastic diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10793509
APP PUB NO 20160237023A1
SERIAL NO

15024175

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and pharmaceutically acceptable salts of the compounds are useful in the treatment of neoplastic diseases or proliferative disorders. The compounds are formulated into pharmaceutical compositions, which can be used in methods of treating neoplastic diseases or proliferative disorders The compounds are useful to treat cancers such as prostate, pancreatic, lung, skin, breast, bladder, colon, and blood cancers. The compounds are represented by the following formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT ZU KOLN50923 KÖLN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berkessel, Albrecht Erftstadt, DE 4 7
Krüger, Mark Hürth, DE 1 0
Kreuzer, Karl-Anton Bonn, DE 1 0
Poll-Wolbeck, Simon Cologne, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 6, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00